<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quantum Pharmaceuticals &#187; absorbtion</title>
	<atom:link href="http://q-pharm.com/category/absorbtion/feed/" rel="self" type="application/rss+xml" />
	<link>http://q-pharm.com</link>
	<description>The drug discovery company</description>
	<lastBuildDate>Thu, 05 Aug 2010 15:05:38 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>From Biological Spectra (multiple protein binding data) to pharmacological profiling!</title>
		<link>http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/</link>
		<comments>http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/#comments</comments>
		<pubDate>Thu, 25 Sep 2008 12:53:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[ADME]]></category>
		<category><![CDATA[absorbtion]]></category>
		<category><![CDATA[active transport]]></category>
		<category><![CDATA[bioavailability]]></category>
		<category><![CDATA[toxicity]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=39</guid>
		<description><![CDATA[An ideal drug cures a decease and does not kill a patient (or even lab animals in the course of preclinical testing). Usual drug discovery paradigm is based on studying a compound&#8217;s properties against a specific, normally decease-related (protein) target. The ability of a compound...


Related posts:<ol><li><a href='http://q-pharm.com/2008/09/from-binding-data-to-pharmacokinetics-a-novel-approach-to-active-drug-absorbtion-prediction/' rel='bookmark' title='Permanent Link: From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction'>From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction</a></li>
<li><a href='http://q-pharm.com/2007/09/quantum-and-albumin-binding-calculations-the-role-of-protein-flexibility/' rel='bookmark' title='Permanent Link: QUANTUM and albumin binding calculations: the role of protein flexibility'>QUANTUM and albumin binding calculations: the role of protein flexibility</a></li>
<li><a href='http://q-pharm.com/2007/12/how-good-are-biological-experiments-herg-binding-data-analysis/' rel='bookmark' title='Permanent Link: How good are biological experiments? HERG binding data analysis'>How good are biological experiments? HERG binding data analysis</a></li>
<li><a href='http://q-pharm.com/2007/12/how-good-are-biological-data-ii-trombine-gsk-gpcr/' rel='bookmark' title='Permanent Link: How good are biological data &#8211; II: Trombine, GSK, GPCR'>How good are biological data &#8211; II: Trombine, GSK, GPCR</a></li>
<li><a href='http://q-pharm.com/2008/01/ld50-vs-mrdd-whats-death-for-a-mice-is-good-enough-for-a-man/' rel='bookmark' title='Permanent Link: LD50 vs. MRDD: what&#8217;s death for a mice is good enough for a man'>LD50 vs. MRDD: what&#8217;s death for a mice is good enough for a man</a></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction</title>
		<link>http://q-pharm.com/2008/09/from-binding-data-to-pharmacokinetics-a-novel-approach-to-active-drug-absorbtion-prediction/</link>
		<comments>http://q-pharm.com/2008/09/from-binding-data-to-pharmacokinetics-a-novel-approach-to-active-drug-absorbtion-prediction/#comments</comments>
		<pubDate>Thu, 25 Sep 2008 12:07:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[ADME]]></category>
		<category><![CDATA[absorbtion]]></category>
		<category><![CDATA[active transport]]></category>
		<category><![CDATA[bioavailability]]></category>
		<category><![CDATA[publications]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=38</guid>
		<description><![CDATA[Oral administered drugs are mainly absorbed in the small intestine. Here, depending on drug composition and size, absorption can happen through a variety of processes . Through the epithelial cells and the lamina pro- pria the drug passes from the lumen into the blood stream...


Related posts:<ol><li><a href='http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/' rel='bookmark' title='Permanent Link: From Biological Spectra (multiple protein binding data) to pharmacological profiling!'>From Biological Spectra (multiple protein binding data) to pharmacological profiling!</a></li>
<li><a href='http://q-pharm.com/2008/10/q-herg-quantums-innovative-approach-to-herg-binding-calculations-is-updated-to-v-2-0/' rel='bookmark' title='Permanent Link: q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is updated to v 2.0'>q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is updated to v 2.0</a></li>
<li><a href='http://q-pharm.com/2008/01/q-herg-quantums-innovative-approach-to-herg-binding-calculations-is-finally-released/' rel='bookmark' title='Permanent Link: q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is finally released'>q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is finally released</a></li>
<li><a href='http://q-pharm.com/2008/09/whats-an-ultimate-value-of-reversible-drug-binding-constant/' rel='bookmark' title='Permanent Link: What&#8217;s an ultimate value of reversible drug binding constant?'>What&#8217;s an ultimate value of reversible drug binding constant?</a></li>
<li><a href='http://q-pharm.com/2007/09/quantum-and-albumin-binding-calculations-the-role-of-protein-flexibility/' rel='bookmark' title='Permanent Link: QUANTUM and albumin binding calculations: the role of protein flexibility'>QUANTUM and albumin binding calculations: the role of protein flexibility</a></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/09/from-binding-data-to-pharmacokinetics-a-novel-approach-to-active-drug-absorbtion-prediction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Model of Intestinal Passive Absorption</title>
		<link>http://q-pharm.com/2008/04/model-of-intestinal-passive-absorption/</link>
		<comments>http://q-pharm.com/2008/04/model-of-intestinal-passive-absorption/#comments</comments>
		<pubDate>Thu, 10 Apr 2008 06:10:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[ADME]]></category>
		<category><![CDATA[absorbtion]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=26</guid>
		<description><![CDATA[Drug penetration from intestinum into blood can be divided into two processes: the drug diffusion to apical membrane of enterocytes and the drug diffusion through the membrane. Let C0, C1 are drug concentrations in the intestinal lumen and in close to intestinal wall, correspondingly; hd...


No related posts.

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/04/model-of-intestinal-passive-absorption/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
